SAFETY, SCIENCE, AND KETAMINE: WHAT THE EVIDENCE SAYS FOR AUSTRALIAN PATIENTS
Australia is in the midst of a mental health crisis. From Sydney to Perth, rates of depression, anxiety, PTSD, and chronic pain are increasing. Conventional medications like SSRIs and antipsychotics, while helpful for many, are failing a significant portion of patients. As these challenges grow, more Australians are turning to alternative treatments. One option gaining attention is ketamine therapy.
Once viewed solely as an anaesthetic, ketamine is now seen as a potentially life-changing treatment for mental health and chronic pain. But is it safe? And what does the science really say?
This comprehensive blog post explores the clinical evidence, safety concerns, treatment options, and legal landscape for ketamine therapy in Australia.
THE RISE OF KETAMINE THERAPY IN AUSTRALIA
Over the past five years, ketamine has moved from the margins to the mainstream in mental health care. Its use is no longer limited to emergency medicine or veterinary procedures. Clinics across the country—from Brisbane to Adelaide—are now offering ketamine infusions for patients with treatment-resistant conditions.
WHY IS IT GAINING TRACTION?
The reason is simple: ketamine works differently than traditional antidepressants. Instead of targeting serotonin or dopamine, ketamine acts on the glutamate system—more specifically, the NMDA receptor. This novel approach produces faster results and offers hope to those who have tried everything else.
Patients report mood improvements within hours or days—not weeks. This can be life-changing, especially for those experiencing suicidal thoughts or unmanageable emotional distress.
THE SCIENCE BEHIND KETAMINE THERAPY
Clinical research has shown ketamine to be effective in treating a range of mental health and pain conditions. While more long-term studies are ongoing, current findings are promising.
MAJOR DEPRESSION
Numerous studies have demonstrated that ketamine can produce rapid and sustained antidepressant effects. A 2020 meta-analysis published in The Lancet Psychiatry reviewed 28 clinical trials and found that ketamine significantly reduced depressive symptoms in patients who had not responded to other treatments.
PTSD
For those with post-traumatic stress disorder, ketamine appears to reduce the intensity of traumatic memories and improve overall emotional regulation. This can help patients better engage in talk therapy and reduce their reliance on long-term medications.
ANXIETY DISORDERS
In generalised anxiety disorder (GAD) and social anxiety disorder, ketamine has shown remarkable short-term reductions in anxiety symptoms. These effects can last up to several weeks after a single infusion, especially when combined with psychotherapy.
CHRONIC PAIN
Ketamine is also used for neuropathic pain, fibromyalgia, and complex regional pain syndrome (CRPS). It reduces central sensitisation and alters pain perception—providing relief where opioids and other analgesics have failed.
IS KETAMINE SAFE FOR AUSTRALIAN PATIENTS?
Safety is a top concern for patients considering ketamine therapy. Fortunately, when administered in a controlled clinical setting, ketamine is considered both safe and well-tolerated.
COMMON SIDE EFFECTS
Short-term side effects are generally mild and include:
- Dizziness
- Nausea
- Visual disturbances
- Feelings of dissociation or detachment
These typically resolve within a few hours after treatment.
LONG-TERM SAFETY
While research is still ongoing, most long-term studies show no significant cognitive decline or organ damage from intermittent, medically supervised ketamine use. However, excessive use outside a clinical setting—especially recreational use—can lead to bladder issues and memory problems.
That’s why treatment must be medically supervised, with careful patient screening and ongoing monitoring.
THE LEGAL AND REGULATORY LANDSCAPE IN AUSTRALIA
IS KETAMINE LEGAL?
Yes, ketamine is legal in Australia when prescribed by a licensed medical practitioner. It is listed as a Schedule 8 controlled substance under the Therapeutic Goods Administration (TGA), which means it has recognised medical use but requires strict regulation. Ketamine therapy for Australian patients
ACCESS THROUGH CLINICS
In recent years, more specialised ketamine clinics have opened in major cities like Melbourne, Sydney, Brisbane, and Perth. Patients usually need a referral from a psychiatrist or GP and must undergo an initial assessment to determine suitability.
Some clinics also offer esketamine (the S-enantiomer of ketamine), which is available as a nasal spray (Spravato®) and may be covered by Medicare under certain conditions.
WHO IS ELIGIBLE FOR KETAMINE THERAPY?
Not everyone qualifies for ketamine treatment. Clinics in Australia typically assess eligibility based on:
- A diagnosis of treatment-resistant depression, PTSD, anxiety, or chronic pain
- Previous failure with at least two antidepressants or other first-line treatments
- No history of psychosis, schizophrenia, or active substance abuse
- Physical health stability
WHAT TO EXPECT DURING TREATMENT
If you’re eligible, treatment often includes:
- IV infusions over a 2–3 week period
- Monitoring by nurses and a physician
- Psychological support during and after sessions
- Follow-up care and ongoing assessments
WHERE CAN PATIENTS IN AUSTRALIA ACCESS TREATMENT?
Here are just a few locations offering ketamine therapy:
- Mind Medicine Australia Clinics (various cities)
- The Invictus Clinic (Brisbane)
- Clarion Clinics (Sydney)
- St Vincent’s Hospital (Melbourne, for esketamine)
- Northside Clinic (ACT)
Regional access remains a challenge, but some clinics are expanding to cities like Fremantle, Bunbury, and Cairns.
WHAT DOES THE FUTURE HOLD?
The future of ketamine therapy in Australia looks bright. New research is underway at universities like Monash, UNSW, and the University of Queensland. These studies aim to further validate ketamine’s efficacy and safety while improving access.
POLICY CHANGES MAY FOLLOW
As data grows, public funding and regulatory frameworks may shift. In fact, esketamine is already partially subsidised under the PBS for treatment-resistant depression. This is an encouraging sign that psychedelic-assisted therapy is becoming more accepted in the Australian healthcare system. Ketamine therapy for Australian patients
FREQUENTLY ASKED QUESTIONS
HOW MUCH DOES KETAMINE THERAPY COST?
Out-of-pocket costs vary widely but usually fall between $400–$800 per infusion. Psychiatrists or clinics offering esketamine under the PBS may reduce costs for eligible patients.
HOW MANY SESSIONS WILL I NEED?
Most treatment plans begin with six infusions over two to three weeks. Maintenance infusions may follow monthly or as needed.
CAN I USE KETAMINE ALONGSIDE OTHER MEDICATIONS?
Yes, but only under medical supervision. Your doctor will review your current medications to avoid interactions.
FINAL THOUGHTS
Ketamine therapy is emerging as a safe, evidence-backed option for Australian patients struggling with depression, anxiety, PTSD, and chronic pain. For many, it provides new hope after years of frustration with traditional treatments.
While it’s not a miracle cure, when used responsibly and as part of a broader treatment plan, ketamine can help people reclaim their lives.
If you’re considering ketamine therapy, speak to a qualified mental health professional and seek treatment from a licensed clinic. The future of mental health in Australia may well lie in this powerful, fast-acting treatment option.